DFT383 in Pediatric Participants With Nephropathic Cystinosis

NCT06910813 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Nephropathic Cystinosis

Interventions

GENETIC: DFT383

Sponsor

Novartis Pharmaceuticals